Intranasal Administration of Neuropeptide Y in PTSD

ID Number 11-1487

Principal Investigator(s)
James Murrough

Department(s) or Division(s)


The purpose of this study is to evaluate the antidepressant and anti-anxiety effect of intranasal administration of neuropeptide Y (NPY) for patients with post-traumatic stress disorder (PTSD). NPY is not approved for the treatment of PTSD and is considered experimental in this study.

One may qualify to take part in this research study if s/he has experienced or witnessed a life-threatening event and is suffering from PTSD. Participation includes a through psychiatric and medical screening. We accept men and women aged 18-65. Participation in this study is expected to last up to one month. Eligible participants will receive treatment at no cost as well as compensation for their time.

Contact Information
Sarah Horn
(212) 241-7910

Recruiting Patients: Yes